Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR09M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,066
Award facts
- Contract value 100% obligated
- $15,065.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $15,065.70 to AmerSourceBergen Drug Corp on January 13, 2026, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 14, 2026, and performance location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor and healthcare solutions provider to federal government agencies, particularly supporting military and veteran healthcare systems through DLA's medical supply chain.
This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits across multiple therapeutic domains. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with potential awards to multiple regional contractors, positioning AmerSourceBergen among the key vendors supporting federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FR09M?
SPE2DR26FR09M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FR09M worth?
The government has obligated $15,066 on SPE2DR26FR09M.
Is contract SPE2DR26FR09M an order under another contract?
Yes. SPE2DR26FR09M is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR09M competed?
The extent of competition for SPE2DR26FR09M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award